Concord Biotech Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
CONCORDBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Concord Biotech has informed the stock exchanges that the trading window for its shares will be closed starting 1st April 2026. The closure will remain in effect until 48 hours after the company declares its audited financial results for the quarter and year ended 31st March 2026. During this period, all designated persons (insiders) and their immediate relatives are prohibited from trading in the company's shares. The date of the board meeting to approve the audited results will be communicated separately.
This is a routine compliance announcement and does not directly affect retail shareholders. However, it signals that the company's FY26 audited results are approaching, which could be a near-term catalyst for the stock once the trading window reopens after the results announcement.